Acne Clinical Trials
Here are the 6 most popular medical studies for acne
Topical Agent
MTC896 Gel for Acne
This study is designed to investigate the efficacy, safety and tolerability of MTC896 Gel in subjects with acne. In this study, MTC896 Gel will be applied at 3 concentrations, twice daily (bid) for 12 weeks and compared against a vehicle control.
Popular filter options for acne trials
Acne Scars Clinical Trials
View 7 Acne Scars medical studies.
Procedure
Fraxel Restore for Acne Scars
Acne scarring is an unfortunate consequence of inflammatory acne vulgaris that often leads to significant cosmetic and psychosocial impacts. Although there have been many advances in the treatment of acne scarring, it remains one of the greatest challenges in cosmetic and laser dermatology. There have been a multitude of studies establishing the efficacy of non-ablative fractional laser therapy for the treatment of atrophic acne scars, and it is widely regarded as one of the best available treatments. More recently, there has been a renewed interest in controlled, non-thermal dermal injury via microneedling devices in the treatment of atrophic acne scars. Where there is a gap in the literature, however, is in the evaluation of the combination of non-ablative fractional laser resurfacing with microneedling in the treatment of atrophic acne scars. The investigators' study will compare the safety and efficacy of using non-ablative fractional laser versus a combination of microneedling and non-ablative fractional laser for atrophic acne scars using a randomized, double-blind, split-face study. The investigators' aim is to further elucidate the pathogenesis of acne scarring and the best approaches for treatment. In doing so, the investigators will study a combination approach to this complex problem in order to better serve future patients.
View More Acne Trials
See another 27 medical studies focused on acne.
Frequently Asked Questions
Introduction to acne
What are the top hospitals conducting acne research?
When it comes to cutting-edge clinical trials for acne treatment, hospitals across the United States are making significant strides. In Sacramento, Integrative Skin Science and Research is leading the way with four active acne trials and a total of four completed trials thus far. Their commitment to advancing dermatological research is evident as they recorded their first acne trial in 2020. Meanwhile, Citruslabs in Santa Monica may have fewer all-time trials under its belt so far but is actively involved in two ongoing acne studies, showing promise for future breakthroughs.
On the East Coast, Ablon Skin Institute & Research Center located in Manhattan Beach proudly conducts two active clinical trials focused on addressing acne concerns. With a track record of two previous successful investigations since initiating their first trial set to launch in 2023, this institution demonstrates dedication to understanding and treating this common skin condition. UnionDerm in New york similarly engages in cutting-edge research by conducting two current acne trials along with having previously completed two such studies after recording their inaugural trial back in 2022.
Rounding out our list is New York Laser & Skin care based also located in New York City. Although they have conducted only one all-time clinical trial for acne thus far (recorded alongside another study initiated backin into 2022), they currently contribute through participating actively withintwo ongoing tests aimed at finding innovative treatment methods.
These hospitals prove that regardless of location or size, dedicated institutions are working tirelessly towards solutions for those affected by acne. Through these scientific endeavors, researchers aim not only to improve individual lives but also enhance our collective understanding of skincare while boosting confidence levels which can be significantly impacted by problematic conditions likeacne
Which are the best cities for acne clinical trials?
When it comes to acne clinical trials, several cities emerge as top contenders for research and innovation. New york City leads the way with 12 active trials focused on treatments like Sofwave, LUT014 Gel (Dose 2), and Straberi Microneedling Treatment. Sacramento, California follows closely behind with 8 ongoing studies exploring interventions such as probiotics, whole almonds in food, and doxycycline. Philadelphia, Pennsylvania boasts 5 active trials investigating treatments like LUT014 Gel (Dose 2) and spironolactone. Finally, Chicago, Illinois and Boston Massachusetts both have a significant presence in acne clinical trials with studies examining various interventions including laser techniques and spironolactone. These cities offer individuals struggling with acne opportunities to participate in cutting-edge research that may pave the way for more effective treatments in the future.
Which are the top treatments for acne being explored in clinical trials?
Clinical trials are shedding light on the top treatments for acne, offering hope to those struggling with this common skin condition. Probiotic therapy is currently being explored in two active trials and has been a part of three all-time acne trials since its introduction in 2020. Another promising option is doxycycline, which is also involved in two ongoing clinical studies and has been a subject of five all-time acne trials since it was first listed back in 2006. As researchers delve deeper into these treatments, they bring us closer to finding effective solutions for individuals battling acne.
What are the most recent clinical trials for acne?
Exciting developments are underway in the realm of acne treatment, as recent clinical trials offer new possibilities for individuals struggling with this condition. One notable study involves electrocautery-incision and BPO group therapy, which has entered its Phase 4 stage and shows promising results. Another trial focuses on clascoterone, a potential breakthrough medication for acne that has progressed through both Phase 1 and Phase 2 successfully. Additionally, Duobrii is an innovative treatment option currently in Phase 3 trials that holds great promise for managing acne symptoms. These advancements highlight the dedication of researchers to finding effective solutions that can improve the lives of those affected by acne.
What acne clinical trials were recently completed?
Several recent clinical trials have made significant strides in the field of acne treatment. In September 2022, Teva Pharmaceuticals USA completed a trial examining Trifarotene 0.005% Topical Cream's efficacy. Additionally, Suzhou Kintor Pharmaceutical Inc.'s GT20029 Gel trial concluded in February 2022, while Galderma R&D wrapped up their study on Trifarotene Cream in December 2021. Edward Lain, MD sponsored a successful Isotretinoin trial that ended in June 2021, along with Bausch Health Americas' IDP-126 Gel and Galderma R&D's second Trifarotene Cream study both completing that same year in May. Further advancements were observed through AnaptysBio's Imsidolimab trial finishing also in May 2021 and Beth Israel Deaconess Medical Center concluding their Altreno investigation in April 2021. Lastly, the Medical University of South carolina achieved progress with an Isotretinoin trial ending November 2020.